Stem Cell Therapy: A Great Leap Forward in Alzheimer’s Treatment
- 460 Downloads
Alzheimer’s disease (AD) is a neurodegenerative disorder and one of the substantial socioeconomic and medical calamities of our time. It is characterized by progressive neurodegenerative disorder featuring dementia and cognitive impairment. It is caused by synaptic failure and the excessive aggregation of two types of misfolded proteins, namely, amyloid-β (Aβ) and tau protein. AD is a complex disease that affects neurons in different parts of the brain. The treatment of AD is difficult with currently available medications and treatment approaches due to inadequate knowledge of its etiology and versatile nature of its pathology. Stem cell holds a promising approach to regenerate the tissue systems and has been explored in various studies of neurodegenerative disorders and provides great research opportunity. Stem cell research-based therapies emit a new hope for AD treatment as a regenerative approach. This chapter focuses on recent advances in stem cell therapies according to cell types and pathophysiology of AD along with human clinical trials of stem cell therapies for the AD.
KeywordsStem cell Alzheimer’s disease Amyloid precursor protein
This work is supported by SERB (EEQ/2018/000114) grant.
Disclosure of Potential Conflicts of Interest
The author(s) declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- ARSI. Alzheimer’s and Related Disorders Society of India (ARDSI) (2010)Google Scholar
- Chen J, Tang YX, Liu YM et al (2012) Transplantation of adipose-derived stem cells is associated with neural differentiation and functional improvement in a rat model of intracerebral hemorrhage. CNS Neurosci Ther 18(10):847–854. https://doi.org/10.1111/j.1755-5949.2012.00382.xCrossRefPubMedPubMedCentralGoogle Scholar
- Cooper O, Hargus G, Deleidi M et al (2010) Differentiation of human ES and Parkinson’s disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol Cell Neurosci 45(3):258–266. https://doi.org/10.1016/j.mcn.2010.06.017CrossRefPubMedPubMedCentralGoogle Scholar
- Gutiérrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J et al (2013) Effects of intravenous administration of allogenic bone marrow-and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther 4(1):11. https://doi.org/10.1186/scrt159CrossRefPubMedPubMedCentralGoogle Scholar
- Lee HJ, Lee JK, Lee H et al (2012) Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer’s disease mouse model through modulation of neuroinflammation. Neurobiol Aging 33(3):588–602. https://doi.org/10.1016/j.neurobiolaging.2010.03.024CrossRefPubMedGoogle Scholar
- Lee JK, Jin HK, Bae JS (2009) Bone marrow-derived mesenchymal stem cells reduce brain amyloid-β deposition and accelerate the activation of microglia in an acutely induced Alzheimer’s disease mouse model. Neurosci Lett 450(2):136–141. https://doi.org/10.1016/j.neulet.2008.11.059CrossRefPubMedGoogle Scholar
- Tabassum N, Verma V, Yadav CB et al (2017) Tissue engineering in regenerative medicine. In: Stem cells from culture dish to clinic. Nova Science Publishers Inc, New York, pp 17–32Google Scholar